Zenotech Laboratories informs about unaudited financial results

10 Aug 2017 Evaluate

Pursuant to the provisions of Regulations 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Zenotech Laboratories has informed that the Board of Directors of the Company, at its meeting held on August 10, 2017, has considered and approved the Unaudited Financial Results along with Limited Review Report issued by the Statutory Auditors for the quarter ended June 30, 2017.

The above information is a part of company’s filings submitted to BSE.

Zenotech Laboratorie Share Price

41.21 -2.89 (-6.55%)
09-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1807.60
Dr. Reddys Lab 1286.40
Cipla 1325.15
Zydus Lifesciences 908.65
Lupin 2301.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×